DENTSPLY SIRONA Inc. (XRAY)

13.73 -0.58 (-4.05%)

As of 2026-03-03 13:31:51 EST

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

Traded asNasdaq: XRAY
ISINUS24906P1093
CIK0000818479
LEI9NHEHR1SOZCYXDO8HO28
EIN391434669
SectorDental equipment
IndustryDental Equipment & Supplies
CEODaniel Scavilla
Employees15,000
Fiscal Year End1231
Address13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277-3607
Phone844-546-3722
Websitehttp://dentsplysirona.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
XRAYDENTSPLY SIRONA Inc.2026-03-03 13:31:5113.73-0.58-4.05
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
XRAY0000818479DENTSPLY SIRONA Inc.US24906P10939NHEHR1SOZCYXDO8HO28391434669Nasdaq3843Dental Equipment & Supplies1231DE13320 BALLANTYNE CORPORATE PLACECHARLOTTENC28277-3607UNITED STATESUS844-546-372213320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277-360713320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277-3607DENTSPLY INTERNATIONAL INC /DE/Dental equipment2016Daniel Scavilla15,000http://dentsplysirona.com5,036,994,579264,500,000199,551,969Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.2026-02-26 17:13:09
This is a preview of the latest data. Subscribe to access the full data.
XRAY Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
XRAY Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20253,158,220,816-1,878,773,763-37.2995199,749,333757,3700.3806
20245,036,994,579-3,425,937,132-40.4817198,991,963-8,371,313-4.037
20238,462,931,711798,329,16210.4158207,363,276-7,998,633-3.714
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Richard C. RosenzweigSecretary, Executive Vice President, General Counsel2024575,42601,196,500260,60186,6102,506,351
Andreas G. FrankChief Business Officer, Executive Vice President2024744,82801,736,851335,178149,1073,528,370
Simon D. CampionChief Executive Officer, President20241,023,11505,033,011767,350229,9988,683,952
Glenn G. ColemanChief Financial Officer, Executive Vice President2024568,07501,929,833012,0753,135,099
Andreas G. FrankChief Business Officer, Executive Vice President2023721,47901,811,457529,620121,2753,746,708
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202514,000
202414,000
202315,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue3,680,000,0003,793,000,0003,965,000,000
Cost Of Revenue1,840,000,0001,835,000,0001,879,000,000
Gross Profit1,840,000,0001,958,000,0002,086,000,000
Research And Development Expenses150,000,000165,000,000184,000,000
General And Administrative Expenses1,438,000,0001,605,000,0001,613,000,000
Operating Expenses
Operating Income-422,000,000-879,000,000-85,000,000
Net Income-598,000,000-910,000,000-132,000,000
Earnings Per Share Basic-3-4.48-0.62
Earnings Per Share Diluted-3-4.48-0.62
Weighted Average Shares Outstanding Basic199,400,000203,200,000212,000,000
Weighted Average Shares Outstanding Diluted199,400,000203,200,000212,000,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents326,000,000272,000,000334,000,000
Marketable Securities Current
Accounts Receivable
Inventories642,000,000564,000,000624,000,000
Non Trade Receivables
Other Assets Current150,000,000153,000,000113,000,000
Total Assets Current2,023,000,0001,746,000,0001,973,000,000
Marketable Securities Non Current
Property Plant And Equipment
Other Assets Non Current284,000,000301,000,000276,000,000
Total Assets Non Current3,406,000,0004,007,000,0005,397,000,000
Total Assets5,429,000,0005,753,000,0007,370,000,000
Accounts Payable300,000,000241,000,000305,000,000
Deferred Revenue74,000,00095,000,00091,000,000
Short Term Debt313,000,000549,000,000322,000,000
Other Liabilities Current700,000,000754,000,000749,000,000
Total Liabilities Current1,343,000,0001,589,000,0001,425,000,000
Long Term Debt2,276,000,0001,748,000,0001,909,000,000
Other Liabilities Non Current544,000,000415,000,000502,000,000
Total Liabilities Non Current2,746,000,0002,221,000,0002,651,000,000
Total Liabilities4,089,000,0003,810,000,0004,076,000,000
Common Stock3,000,0003,000,0003,000,000
Retained Earnings-1,564,000,000-835,000,000205,000,000
Accumulated Other Comprehensive Income-639,000,000-730,000,000-636,000,000
Total Shareholders Equity1,339,000,0001,942,000,0003,293,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization352,000,000349,000,000343,000,000
Share Based Compensation Expense33,000,00039,000,00046,000,000
Other Non Cash Income Expense10,000,0009,000,0005,000,000
Change In Accounts Receivable91,000,000-104,000,00058,000,000
Change In Inventories17,000,000-17,000,000-6,000,000
Change In Non Trade Receivables
Change In Other Assets
Change In Accounts Payable11,000,000-30,000,00014,000,000
Change In Other Liabilities-74,000,000-39,000,000-16,000,000
Cash From Operating Activities235,000,000461,000,000377,000,000
Purchases Of Marketable Securities
Sales Of Marketable Securities
Acquisition Of Property Plant And Equipment131,000,000180,000,000149,000,000
Acquisition Of Business
Other Investing Activities-3,000,0006,000,000-1,000,000
Cash From Investing Activities-132,000,000-197,000,000-89,000,000
Tax Withholding For Share Based Compensation
Payments Of Dividends128,000,000128,000,000118,000,000
Issuance Of Common Stock
Repurchase Of Common Stock0250,000,000300,000,000
Issuance Of Long Term Debt553,000,0001,000,0000
Repayment Of Long Term Debt147,000,00088,000,0007,000,000
Other Financing Activities-6,000,000-16,000,000-10,000,000
Cash From Financing Activities-80,000,000-302,000,000-307,000,000
Change In Cash54,000,000-62,000,000-31,000,000
Cash At End Of Period326,000,000272,000,000334,000,000
Income Taxes Paid71,000,00074,000,000177,000,000
Interest Paid66,000,00091,000,00097,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-3-4.48-0.62
Price To Earnings Ratio-3.81-4.2366-57.4032
Earnings Growth Rate-33.0357622.5806-85.941
Price Earnings To Growth Ratio0.1153-0.00680.6679
Book Value Per Share6.72029.56215.5377
Price To Book Ratio1.70091.98492.2906
Ebitda-87,000,000-418,000,000469,000,000
Enterprise Value4,542,142,0005,881,736,0009,442,080,000
Dividend Yield0.05620.03320.0156
Dividend Payout Ratio-0.214-0.1407-0.8939
Debt To Equity Ratio1.93351.18280.6775
Capital Expenditures
Free Cash Flow
Return On Equity-0.4466-0.4686-0.0401
One Year Beta1.09440.61210.9941
Three Year Beta0.95960.80510.8661
Five Year Beta0.89410.88280.8956
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
MAZELSKY JONATHAN JAYDirector2026-12-312,637A14,381
Scavilla Daniel TDirector, President, CEO & Member of BOD2026-02-241,194D16,750
Zurbay DonaldDirector2026-01-266,871A6,871
Barber Michael JDirector2026-01-09245A17,944
Czerney KevinVP, Chief Accounting Officer2026-01-09262A28,040
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Angus S King, Jr.Senator2014-05-13Sale (Full)2014-04-28Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Gilbert Cisneros2025-02-11CA31Sale (Partial)2025-01-07$1,001 - $15,000
Gilbert Cisneros2025-02-11CA31Sale2025-01-08$1,001 - $15,000
Lois Frankel2022-01-16FL21Sale (Partial)2021-12-03$1,001 - $15,000
Lois Frankel2022-01-16FL21Sale2021-12-05$1,001 - $15,000
Lois Frankel2019-05-21FL21Purchase2019-05-09$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Anchor Investment Management, LLC2025-12-316,09253311.4296
Villanova Investment Management Co LLC2025-12-311,742,001152,40611.43
Bell Investment Advisors, Inc2025-12-314584011.45
Pacer Advisors, Inc.2025-12-31272,73123,86111.43
Kera Capital Partners, Inc.2025-12-31170,82713,69912.47
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
LAZARD FUNDS INC2025-12-31Open SharesLZFOX134,7321,539,986.764.108
LAZARD FUNDS INC2025-12-31Institutional SharesLZFIX134,7321,539,986.764.108
PIMCO Equity Series2025-12-31Class APMJAX1,480,60816,923,349.440.563
PIMCO Equity Series2025-12-31I-2PMJPX1,480,60816,923,349.440.563
PIMCO Equity Series2025-12-31Institutional ClassPMJIX1,480,60816,923,349.440.563
This is a preview of the latest data. Subscribe to access the full data.